Vincerx Pharma Inc Net Income per Employee (VINC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Vincerx Pharma Inc   (VINC)
 

Vincerx Pharma Inc Net Income per Employee

VINC's Quarterly Results, Trends, Rankings, Statistics
Vincerx Pharma Inc recorded a cumulative net loss of $-23 million during 12 month ending in the first quarter 2025.
The Healthcare sector has seen employees of 388 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 4318, from total ranking in previous quarter at 4989.


What is Income per Employee Ratio?






VINC Net Income per Employee (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,887,083 -2,506,167 -2,252,500 -2,349,500 -3,128,083
VINC's Total Ranking # 4318 # 4989 # 4426 # 4461 # 4556
Seq. Net Income Change - - - - -


VINC Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 389
Healthcare Sector # 852
Overall Market # 4318

Net Income per Employee Statistics
High Average Low
$ 955 $ -2,971,372 $ -5,486,750
(Dec 31 2020)   (Jun 30 2022)







Companies with similar Income per Employee for 12 month ending Mar 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2025Number of Employees Mar 31 2025


Date modified: 2026-08-29T17:41:27+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.